StockData
XBiotech Inc. logo

XBiotech Inc. (XBIT) stock

XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.96+0.00 (0.00%)

Close on Nov 13, 2026Market cap $59.76MP/E –Yield –

XBiotech enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

XBiotech's enterprise value was -$50.08M on Nov 11, 2026, against -$78.16M a year earlier. Over the last 5 years it ranged from -$121.48M to $99.45M, with a median of -$59.55M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$50.08M–
2025Dec 31, 2025-$74.50M–
2024Dec 31, 2024-$62.72M–
2023Dec 29, 2023-$80.44M–
2022Dec 30, 2022-$113.26M-213.9%
2021Dec 31, 2021$99.45M-54.6%
2020Dec 31, 2020$218.93M-69.9%
2019Dec 31, 2019$726.17M+350.7%
2018Dec 31, 2018$161.12M+60.1%
2017Dec 29, 2017$100.65M-64.3%
2016Dec 30, 2016$281.54M+16.0%
2015Dec 31, 2015$242.74M–

More XBiotech figures

See a number that looks wrong?